Dr. Martens (LON:DOCS) Shares Up 1.6% – Here’s What Happened

Dr. Martens plc (LON:DOCS) shares shot up 1.6% on Friday . The company traded as high as GBX 83.80 and last traded at GBX 83.49. 740,729 shares changed hands during trading, a decline of 90% from the average session volume of 7,520,830 shares. The stock had previously closed at GBX 82.20.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Royal Bank Of Canada restated a “sector perform” rating and issued a GBX 100 price objective on shares of Dr. Martens in a research report on Tuesday, June 2nd. Berenberg Bank decreased their target price on Dr. Martens from GBX 114 to GBX 110 and set a “buy” rating on the stock in a research note on Tuesday, May 19th. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of GBX 105.

Dr. Martens Stock Performance

The company has a market capitalization of £799.13 million, a P/E ratio of 34.79, a P/E/G ratio of 6.40 and a beta of 0.24. The company has a debt-to-equity ratio of 108.85, a quick ratio of 1.13 and a current ratio of 2.61. The business’s fifty day simple moving average is GBX 73.70 and its 200-day simple moving average is GBX 69.01.

Dr. Martens (LON:DOCS) last released its quarterly earnings data on Tuesday, May 19th. The company reported GBX 4.20 EPS for the quarter. Dr. Martens had a net margin of 3.11% and a return on equity of 6.89%. The business had revenue of £764.90 million during the quarter. As a group, equities analysts anticipate that Dr. Martens plc will post 2.5809394 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider Ije Nwokori purchased 118,516 shares of the company’s stock in a transaction that occurred on Thursday, June 25th. The stock was bought at an average cost of GBX 72 per share, with a total value of £85,331.52. Also, insider Giles Wilson purchased 68,313 shares of the business’s stock in a transaction on Thursday, June 25th. The shares were purchased at an average price of GBX 72 per share, with a total value of £49,185.36. Over the last three months, insiders have purchased 300,199 shares of company stock valued at $22,061,408. 2.94% of the stock is owned by corporate insiders.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.